欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  MAPK/ERK Pathway  /  MNK  /  Tinodasertib

CAS No.: 1464151-33-4

Tinodasertib Catalog No. CSN22399

Synonyms: ETC-1907206

ETC-206 is a selective MNK1 and MNK2 inhibitor with IC50s of 64 nM and 86 nM, respectively.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT03414450Ph+ Acute Lymphoblastic Leukem... more >>ia (Ph+ALL) Ph- Acute Lymphoblastic Leukemia (Ph-ALL) Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+) Collapse <<Phase 1Withdrawn(Withdrawal requested... more >> by D3) Collapse <<February 2023United States, Georgia ... more >> Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Maryland The Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20874 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Singapore Singapore General Hospital Singapore, Singapore, 169608 Collapse <<

实验方案

技术信息

CAS号 1464151-33-4 储存条件
分子式 C25H20N4O2 运输 蓝冰
分子量 408.45 别名 ETC-1907206
溶解度
DMSO82.0 mg/mL (200.8 mM)
WaterInsoluble
EthanolInsoluble
动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们